Skip to content

cTBS treatment for auditory hallucinations in schizophrenia: a randomized controlled trial.

cTBS treatment for auditory hallucinations in schizophrenia: a randomized controlled trial.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052759
Enrollment
Unknown
Registered
2021-11-05
Start date
2021-11-06
Completion date
Unknown
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

auditory hallucinations in schizophrenia

Interventions

Experimental group:continuous theta burst stimulation, cTBS
Control group:sham continuous theta burst stimulation

Sponsors

Ningbo Kangning Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients with schizophrenia (SZ) should be evaluated by clinical psychiatrists and meet the diagnostic criteria of ICD-10 (ICD); 2. Aged 18-50 years, currently receiving two or more antipsychotic drugs and the symptoms of auditory hallucinations persist; 3. The frequency of occurrence is more than 5 times a day; 4. There is no metal in the brain, no history of epilepsy in the past, and can cooperate with various experimental examinations; 5. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. History of brain trauma or head surgery; 2. For those with a pacemaker installed, the subject wears an in-ear hearing aid; 3. Combined with a history of other mental illnesses, such as depression, autism, developmental delay and a history of past drug abuse, recent suicidal tendencies, etc.

Design outcomes

Primary

MeasureTime frame
Positive and negative symptom scale;Auditory hallucination scale;Brain evoked and event-related potentials;Functional near-infrared spectroscopy ;

Secondary

MeasureTime frame
Side effect scale;Repetitive neuropsychological state test;

Countries

China

Contacts

Public ContactLiu Xiaoli

Ningbo Kangning Hospital

1206207800@qq.com+86 18268694753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026